Imexpharm Corporation Announces Earnings Results for the Full Year of Fiscal 2015; Provides Earnings Guidance for the Full Year of Fiscal 2016
The company provided earnings guidance for the full year of fiscal 2016. For the year, the company expects total revenue to be VND 1,100 million and profit before tax to be VND 140 million.